KDMNのチャート
KDMNの企業情報
| symbol | KDMN |
|---|---|
| 会社名 | Kadmon Holdings Inc （KADMON HOLDINGS） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | カドモン･ホールディングス(Kadmon Holdings Inc)(旧名: Kadmon Holdings LLC)は小分子･バイオ製剤の発見･開発･商業化に従事するバイオ医薬品会社である。同社は自己免疫･繊維性･腫瘍･遺伝性疾患の治療向けの候補製品を開発する。同社は腫瘍治療のKD025とTesevatinib、多発性嚢胞腎(PKD)治療のTesevatinib及びKD034を含む。同社はRibasphere RibaPak、Ribasphereタブレット、Ribasphere、Qsymia、Tetrabenazine及びValganciclovirを含む錠剤･カプセルを提供する。KD025は経口選択的ROCK2 阻害剤であるrhoキナーゼ2プラットフォームにおける候補製品である。Tesevatinibは腫瘍増殖･転移･薬物耐性のドライバー分子を阻害する経口チロシン･キナーゼ阻害薬(TKI)である。KD034は体内の過剰銅を除去するキレート化合物である塩酸トリエンチン製剤のウィルソン病治療のポートフォリオである。 カドモン・ホ―ルディングスは米国のバイオ医薬品持株会社。子会社を通じ、バイオ製剤の開発・商業化に従事する。自己免疫機能を取り入れ、線維性疾患、がん、遺伝病などの治療向けに小分子やバイオ製剤を開発。同社の候補薬には多発性嚢胞腎治療の「KD034」と「Tesevatinib」などがある。本社はニューヨーク。 Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. |
| 本社所在地 | 450 East 29th Street New York NY 10016 USA |
| 代表者氏名 | Tasos G. Konidaris |
| 代表者役職名 | Interim Chairman of the Board |
| 電話番号 | +1 212-308-6000 |
| 設立年月日 | 40422 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 116人 |
| url | www.kadmon.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -84.31500 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 368.03760 |
| 売上高 | （百万ドル） 1.39600 |
| 企業価値(EV) | （百万ドル） 343.00860 |
| 当期純利益 | （百万ドル） -56.86300 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Kadmon Holdings Inc revenues decreased 89% to $1.4M. Net loss applicable to common stockholders excluding extraordinary items decreased 31% to $56.9M. Revenues reflect License and other revenue decrease of 90% to $705K Net sales decrease of 87% to $691K. Lower net loss reflects Loss on equity method investment decrease of 84% to $1.2M (expense). |
KDMNのテクニカル分析
KDMNのニュース
Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Kadmon Holdings, Inc. (NASDAQ:KDMN) 2021/11/12 09:12:45 Dakota Financial News
Kadmon Holdings, Inc. (NASDAQ:KDMN) Investment analysts at Jefferies Financial Group dropped their FY2023 EPS estimates for Kadmon in a research note issued to investors on Monday, November 8th. Jefferies Financial Group analyst C. Howerton now expects that the company will post earnings per share of $0.05 for the year, down from their previous estimate []
Millennium Management LLC Grows Stock Position in Kadmon Holdings, Inc. (NASDAQ:KDMN) 2021/11/11 11:54:42 Transcript Daily
Millennium Management LLC increased its holdings in Kadmon Holdings, Inc. (NASDAQ:KDMN) by 19.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,197,598 shares of the companys stock after buying an additional 860,349 shares during the period. Millennium Management LLC owned about 3.02% []
Kadmon (NASDAQ:KDMN) Sees Unusually-High Trading Volume 2021/11/10 12:00:41 Transcript Daily
Shares of Kadmon Holdings, Inc. (NASDAQ:KDMN) saw an uptick in trading volume on Monday . 133,981 shares changed hands during mid-day trading, a decline of 97% from the previous session’s volume of 5,061,039 shares.The stock last traded at $9.49 and had previously closed at $9.48. A number of research firms have recently commented on KDMN. […]
Kadmon (NASDAQ:KDMN) Hits New 12-Month High at $9.50 2021/11/10 00:10:41 Dakota Financial News
Shares of Kadmon Holdings, Inc. (NASDAQ:KDMN) hit a new 52-week high during trading on Tuesday . The stock traded as high as $9.50 and last traded at $9.50, with a volume of 1052 shares. The stock had previously closed at $9.50. Several brokerages recently commented on KDMN. UBS Group cut Kadmon from a buy rating []
Enamoring stocks: Kadmon Holdings, Inc. (NASDAQ:KDMN 0.11%), Switch, Inc. (NYSE:SWCH -12.05%) 2021/11/08 01:41:37 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enamoring stocks: Kadmon Holdings, Inc. (NASDAQ:KDMN 0.11%), Switch, Inc. (NYSE:SWCH -12.05%) appeared first on Stocks Equity .